Tekturna and Breastfeeding

Although no human studies have been done on Tekturna (aliskiren) and breastfeeding, the drug does pass through breast milk in rats. This is a good indication that Tekturna may also pass through breast milk in humans. However, it is unknown whether this could cause problems in a nursing infant. If you are taking Tekturna and breastfeeding at the same time, talk with your healthcare provider.

Tekturna Medication Information

Tekturna and Breastfeeding: An Overview

At this time, it is unknown if Tekturna^® (aliskiren hemifumarate) passes through breast milk. The manufacturer recommends that women avoid this drug while breastfeeding. If you are breastfeeding or are thinking about breastfeeding, talk with your healthcare provider before taking Tekturna.

Tekturna and Breastfeeding: What Does the Research Say?

No studies have been done to see if Tekturna passes through breast milk in women. However, it has been shown to pass through breast milk in rats, which is a good indication that it probably does so in humans as well. Because Tekturna has not been adequately studied in any infants or children, it is not known if the drug could have any negative effects on an infant (or on a mother's milk supply) if it does pass through breast milk.

Talking With Your Healthcare Provider About Tekturna and Breastfeeding

You should talk with your healthcare provider about Tekturna and breastfeeding.

Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision about Tekturna and breastfeeding that is right for you.